AllNewsPhotosVideos
Serum Institute Of India

Serum Institute Of India

Serum institute of india, Latest News

Serum Institute of India is a manufacturer of immunobiological drugs including vaccines in India. It was founded by Cyrus Poonawalla in 1966.The company is the world's largest vaccine producer by number of doses produced. It is currently developing an intra-nasal swine flu vaccine.
Read More
Nepal yet to receive 1 million COVID vaccine doses purchased from India: Envoy - Hindi News | Nepal yet to receive 1 million COVID vaccine doses purchased from India: Envoy | Latest international News at Lokmattimes.com

International :Nepal yet to receive 1 million COVID vaccine doses purchased from India: Envoy

Nepal on Friday said it is yet to receive a million doses of COVID-19 vaccines from India, for which the advance payment has already been done. ...

Netherlands becomes latest EU country to approve Covishield vaccine - Hindi News | Netherlands becomes latest EU country to approve Covishield vaccine | Latest international News at Lokmattimes.com

International :Netherlands becomes latest EU country to approve Covishield vaccine

The Netherlands became the latest European Union (EU) country to approve the Serum Institute of India (SII)-manufactured Covishield vaccine for travellers, days after India pushed for the approval of its COVID-19 vaccines in Europe. ...

COVID will be eliminated in 2-3 years, says Adar Poonawalla - Hindi News | COVID will be eliminated in 2-3 years, says Adar Poonawalla | Latest national News at Lokmattimes.com

National :COVID will be eliminated in 2-3 years, says Adar Poonawalla

Adar Poonawalla, CEO, Serum Institute of India, while discussing the challenges of vaccine supply. He commented on what needs ... ...

'Submit results on Covavax adult trials first': Govt panel to SII on Covid-19 vaccine trials for children - Hindi News | 'Submit results on Covavax adult trials first': Govt panel to SII on Covid-19 vaccine trials for children | Latest national News at Lokmattimes.com

National :'Submit results on Covavax adult trials first': Govt panel to SII on Covid-19 vaccine trials for children

An expert panel constituted by the government has recommended against granting permission to the Serum Institute of India (SII) to conduct phase two and three clinical trials of Covavax COVID-19 vaccine on children aged between 2-17 years, said sourc ...

SII not allowed to conduct phase 2 & 3 clinical trials of Covavax vaccine on children - Hindi News | SII not allowed to conduct phase 2 & 3 clinical trials of Covavax vaccine on children | Latest national News at Lokmattimes.com

National :SII not allowed to conduct phase 2 & 3 clinical trials of Covavax vaccine on children

Pune's Serum Institute, which has come under a lot of discussion due to Covishield, has suffered a major setback. ... ...

Covishield will get EMA approval in a month, says Adar Poonawala at Indian Global Forum 2021 - Hindi News | Covishield will get EMA approval in a month, says Adar Poonawala at Indian Global Forum 2021 | Latest national News at Lokmattimes.com

National :Covishield will get EMA approval in a month, says Adar Poonawala at Indian Global Forum 2021

Serum Institute of India is confident of receiving approval from the European Medicines Agency (EMA) for its COVID-19 vaccine Covishield in a month, the company's CEO Adar Poonawalla informed on Wednesday. ...

No ban on Covishield, European Medicines Agency can't start any procedure without request: EU Ambassador to India - Hindi News | No ban on Covishield, European Medicines Agency can't start any procedure without request: EU Ambassador to India | Latest international News at Lokmattimes.com

International :No ban on Covishield, European Medicines Agency can't start any procedure without request: EU Ambassador to India

EU Ambassador to India Ugo Astuto has clarified that there is no ban in the European Union on Covishield vaccine produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford University. ...

EU travel issues faced by Indians given Covishield taken up at 'highest level', says Adar Poonawalla - Hindi News | EU travel issues faced by Indians given Covishield taken up at 'highest level', says Adar Poonawalla | Latest national News at Lokmattimes.com

National :EU travel issues faced by Indians given Covishield taken up at 'highest level', says Adar Poonawalla

Adar Poonawalla, Chief Executive Officer (CEO) and owner of the Serum Institute of India (SII) on Monday assured Indians who have taken Covishield doses and are now facing issues while travelling to European Union countries that the matter had been e ...